6ehy
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery== | ==scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery== | ||
| - | <StructureSection load='6ehy' size='340' side='right' caption='[[6ehy]], [[Resolution|resolution]] 2.25Å' scene=''> | + | <StructureSection load='6ehy' size='340' side='right'caption='[[6ehy]], [[Resolution|resolution]] 2.25Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[6ehy]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6EHY OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6EHY FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[6ehy]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6EHY OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6EHY FirstGlance]. <br> |
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6ehy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6ehy OCA], [http://pdbe.org/6ehy PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6ehy RCSB], [http://www.ebi.ac.uk/pdbsum/6ehy PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6ehy ProSAT]</span></td></tr> | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6ehy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6ehy OCA], [http://pdbe.org/6ehy PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6ehy RCSB], [http://www.ebi.ac.uk/pdbsum/6ehy PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6ehy ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Antibody 3D structures|Antibody 3D structures]] | ||
| + | *[[Monoclonal Antibodies 3D structures|Monoclonal Antibodies 3D structures]] | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Human]] | ||
| + | [[Category: Large Structures]] | ||
[[Category: Hargreaves, D]] | [[Category: Hargreaves, D]] | ||
[[Category: Abvance]] | [[Category: Abvance]] | ||
Revision as of 07:06, 16 October 2019
scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery
| |||||||||||
